| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACBD3
|
acyl-CoA binding domain containing 3
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACTB
|
actin, beta
|
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast)
|
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast)
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM23
|
ADAM metallopeptidase domain 23
|
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADPRH
|
ADP-ribosylarginine hydrolase
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APBB1IP
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARHGAP26
|
Rho GTPase activating protein 26
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ATG3
|
autophagy related 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
AURKA
|
aurora kinase A
|
|
AXIN1
|
axin 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX1
|
brain expressed, X-linked 1
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP3
|
bone morphogenetic protein 3
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BTF3
|
basic transcription factor 3
|
|
C20ORF85
|
chromosome 20 open reading frame 85
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
C3
|
complement component 3
|
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1
|
|
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3
|
|
CADM1
|
cell adhesion molecule 1
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD1E
|
CD1e molecule
|
|
CD24
|
CD24 molecule
|
|
CD28
|
CD28 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD84
|
CD84 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC37
|
cell division cycle 37
|
|
CDC42
|
cell division cycle 42
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDHR5
|
cadherin-related family member 5
|
|
CDIPT
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CELF2
|
CUGBP, Elav-like family member 2
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFHR1
|
complement factor H-related 1
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CLDN7
|
claudin 7
|
|
CLNS1A
|
chloride channel, nucleotide-sensitive, 1A
|
|
CLU
|
clusterin
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX2
|
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CST2
|
cystatin SA
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CUL4A
|
cullin 4A
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCAF7
|
DDB1 and CUL4 associated factor 7
|
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEK
|
DEK proto-oncogene
|
|
DENND2D
|
DENN/MADD domain containing 2D
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOC2B
|
double C2-like domains, beta
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPT
|
dermatopontin
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DRD4
|
dopamine receptor D4
|
|
DSC3
|
desmocollin 3
|
|
DSP
|
desmoplakin
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
E2F1
|
E2F transcription factor 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNA1
|
ephrin-A1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EHD3
|
EH-domain containing 3
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENG
|
endoglin
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERN2
|
endoplasmic reticulum to nucleus signaling 2
|
|
ERP29
|
endoplasmic reticulum protein 29
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV1
|
ets variant 1
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXO1
|
exonuclease 1
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXE1
|
forkhead box E1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FRZB
|
frizzled-related protein
|
|
FSCN2
|
fascin actin-bundling protein 2, retinal
|
|
FUS
|
FUS RNA binding protein
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GALR2
|
galanin receptor 2
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GATA6
|
GATA binding protein 6
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLO1
|
glyoxalase I
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7
|
|
GNMT
|
glycine N-methyltransferase
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOLGA3
|
golgin A3
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPC3
|
glypican 3
|
|
GPC5
|
glypican 5
|
|
GPSM1
|
G-protein signaling modulator 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2B
|
general transcription factor IIB
|
|
GYG1
|
glycogenin 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBD
|
hemoglobin, delta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC6
|
histone deacetylase 6
|
|
HEPACAM2
|
HEPACAM family member 2
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HOPX
|
HOP homeobox
|
|
HOXB13
|
homeobox B13
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AA2P
|
heat shock protein 90kDa alpha (cytosolic), class A member 2, pseudogene
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HTT
|
huntingtin
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI35
|
interferon-induced protein 35
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL17A
|
interleukin 17A
|
|
IL3
|
interleukin 3
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
IPO13
|
importin 13
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAG2
|
jagged 2
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUP
|
junction plakoglobin
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KIF11
|
kinesin family member 11
|
|
KIF1A
|
kinesin family member 1A
|
|
KIF2C
|
kinesin family member 2C
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT16
|
keratin 16, type I
|
|
KRT20
|
keratin 20, type I
|
|
L1RE1
|
LINE1 retrotransposable element 1
|
|
LAPTM5
|
lysosomal protein transmembrane 5
|
|
LARS2
|
leucyl-tRNA synthetase 2, mitochondrial
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LDHB
|
lactate dehydrogenase B
|
|
LDLR
|
low density lipoprotein receptor
|
|
LDOC1
|
leucine zipper, down-regulated in cancer 1
|
|
LEP
|
leptin
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LIMD1
|
LIM domains containing 1
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LTF
|
lactotransferrin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYPLA1
|
lysophospholipase I
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPRE1
|
microtubule-associated protein, RP/EB family, member 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAST2
|
microtubule associated serine/threonine kinase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MBP
|
myelin basic protein
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR122
|
microRNA 122
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR126
|
microRNA 126
|
|
MIR137
|
microRNA 137
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR20B
|
microRNA 20b
|
|
MIR21
|
microRNA 21
|
|
MIR223
|
microRNA 223
|
|
MIR29A
|
microRNA 29a
|
|
MIR30A
|
microRNA 30a
|
|
MIR498
|
microRNA 498
|
|
MIR874
|
microRNA 874
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7A3
|
microRNA let-7a-3
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP25
|
matrix metallopeptidase 25
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MT1G
|
metallothionein 1G
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYLK
|
myosin light chain kinase
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOCD
|
myocardin
|
|
NAA11
|
N(alpha)-acetyltransferase 11, NatA catalytic subunit
|
|
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha
|
|
NBN
|
nibrin
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NELL1
|
NEL-like 1 (chicken)
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NLK
|
nemo-like kinase
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NRP1
|
neuropilin 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUCB2
|
nucleobindin 2
|
|
NUP214
|
nucleoporin 214kDa
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OXA1L
|
oxidase (cytochrome c) assembly 1-like
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX7
|
paired box 7
|
|
PBRM1
|
polybromo 1
|
|
PCDH7
|
protocadherin 7
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PEAR1
|
platelet endothelial aggregation receptor 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEG3
|
paternally expressed 3
|
|
PENK
|
proenkephalin
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PITX1
|
paired-like homeodomain 1
|
|
PKN1
|
protein kinase N1
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD2
|
phospholipase D2
|
|
PLP1
|
proteolipid protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PPP1R8
|
protein phosphatase 1, regulatory subunit 8
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDM7
|
PR domain containing 7
|
|
PRDM9
|
PR domain containing 9
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRL
|
prolactin
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT6
|
protein arginine methyltransferase 6
|
|
PRNP
|
prion protein
|
|
PROM1
|
prominin 1
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PUS10
|
pseudouridylate synthase 10
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALBP1
|
ralA binding protein 1
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2
|
|
RBP3
|
retinol binding protein 3, interstitial
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RET
|
ret proto-oncogene
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPRM
|
reprimo, TP53 dependent G2 arrest mediator candidate
|
|
RPSA
|
ribosomal protein SA
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCUBE1
|
signal peptide, CUB domain, EGF-like 1
|
|
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans)
|
|
SELENBP1
|
selenium binding protein 1
|
|
SEPT9
|
septin 9
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SETX
|
senataxin
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFTPD
|
surfactant protein D
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHOX
|
short stature homeobox
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SKI
|
SKI proto-oncogene
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
|
SLC39A1
|
solute carrier family 39 (zinc transporter), member 1
|
|
SLC39A4
|
solute carrier family 39 (zinc transporter), member 4
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SNAPIN
|
SNAP-associated protein
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SS18L1
|
synovial sarcoma translocation gene on chromosome 18-like 1
|
|
SSRP1
|
structure specific recognition protein 1
|
|
ST7
|
suppression of tumorigenicity 7
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK39
|
serine threonine kinase 39
|
|
STMN1
|
stathmin 1
|
|
STRAP
|
serine/threonine kinase receptor associated protein
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila)
|
|
SYNPO2
|
synaptopodin 2
|
|
SYVN1
|
synovial apoptosis inhibitor 1, synoviolin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAGLN
|
transgelin
|
|
TARDBP
|
TAR DNA binding protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TJP1
|
tight junction protein 1
|
|
TKT
|
transketolase
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TNS4
|
tensin 4
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TP53
|
tumor protein p53
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP53INP2
|
tumor protein p53 inducible nuclear protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIP12
|
thyroid hormone receptor interactor 12
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTK
|
TTK protein kinase
|
|
TXN
|
thioredoxin
|
|
TYMS
|
thymidylate synthetase
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
UNC13B
|
unc-13 homolog B (C. elegans)
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
VAMP8
|
vesicle-associated membrane protein 8
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VTI1B
|
vesicle transport through interaction with t-SNAREs 1B
|
|
VTN
|
vitronectin
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZMYM2
|
zinc finger, MYM-type 2
|
|
ZMYND10
|
zinc finger, MYND-type containing 10
|
|
ZNF217
|
zinc finger protein 217
|
